Skip to content

Income Tax at other companies

Merck & Co. logo
Merck & Co.MRK
$709M-13.3%
Amgen logo
AmgenAMGN
$265M+9.1%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$104M+8.0%
Eli Lilly logo
Eli LillyLLY
$1.45B+109%

Other financials

Income statement

See full
Revenue$3.0M+2.1%
Operating income-$58.4M+15.2%
Net income-$48.4M-22.6%
EPS (diluted)-$0.40-17.6%

Balance sheet

See full
Cash & equivalents$457.6M-38.9%
Total debt$23.0K-94.1%
Total equity$665.2M-14.4%
Total assets$732.6M-10.5%

Cash flow

See full
Operating cash flow-$30.6M+16.1%
CapEx$38.0K+138%
Free cash flow-$30.6M+16.0%

Valuation

See full
Market cap$3.67B+63.7%

Profitability

See full
Operating margin-953.6%-3,536pp
Net margin-942.8%-3,477pp
FCF margin-630.1%-6,324pp

Returns & leverage

See full
Return on equity-29.5%-1.8pp
Current ratio9.8×-10.2×

Where this comes from

Reported directly by NewAmsterdam Pharma Company in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: NewAmsterdam Pharma Company’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about NewAmsterdam Pharma Company's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NewAmsterdam Pharma Company's income tax?
NewAmsterdam Pharma Company (NAMS) reported income tax of -$1K in Q3 2024.
How has NewAmsterdam Pharma Company's income tax changed year-over-year?
NewAmsterdam Pharma Company's income tax decreased by 114.8% year-over-year, from $6.75K to -$1K.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.